Home›Search›Seminars in Thrombosis and Hemostasis

Seminars in Thrombosis and Hemostasis

Thieme Medical Publishers, Inc. · United States · Est. 1914

ISSN1098-9064

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.095

H-Indexi

136

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.912

Total Worksi

4,430

Total Citationsi

132,497

2yr Mean Citednessi

4.80

Open Impact Factor alternative

Aims & Scope

Seminars in Thrombosis & Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis & Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions. The journal also publishes peer reviewed original research papers. Seminars in Thrombosis & Hemostasis offers an informed perspective on today's pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1914

Frequency8

StatusActive (last: 2026)

Total Publications4,430

Publisher OrgThieme Medical Publishers (Germany)

Visit Journal Website

Submission Info

Peer Reviewpeer reviewed

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

7/12 · 58%

✅

Do you know the journal / publisher?

Thieme Medical Publishers, Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1098-9064

✅

Indexed in a trusted database?

WoS, Scopus

✅

Peer review process documented?

peer reviewed

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

132

4.2k

2019

105

2.8k

2020

144

2.3k

2021

153

2022

120

1.2k

2023

124

841

2024

118

169

2025

496

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ1

HematologyQ1

Subject Classification

Web of Science Categories

HematologyPeripheral Vascular Diseases

Scopus Categories

HematologyCardiology and Cardiovascular Medicine

Research Topics (OpenAlex)

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsPlatelet Disorders and TreatmentsHemophilia Treatment and ResearchAntiplatelet Therapy and Cardiovascular DiseasesHeparin-Induced Thrombocytopenia and ThrombosisAtrial Fibrillation Management and OutcomesBlood properties and coagulationCoagulation, Bradykinin, Polyphosphates, and AngioedemaMyeloproliferative Neoplasms: Diagnosis and Treatment

Frequently asked questions about Seminars in Thrombosis and Hemostasis

Is Seminars in Thrombosis and Hemostasis a predatory journal?

PubScope has no integrity flags on record for Seminars in Thrombosis and Hemostasis: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Seminars in Thrombosis and Hemostasis?

Seminars in Thrombosis and Hemostasis is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.80.

Is Seminars in Thrombosis and Hemostasis indexed in Scopus and Web of Science?

Seminars in Thrombosis and Hemostasis is indexed in Web of Science, Scopus.